Psaty B M, Koepsell T D, Wagner E H, LoGerfo J P, Inui T S
Department of Medicine, University of Washington, Seattle.
JAMA. 1990;263(12):1653-7.
We conducted a population-based, case-control study of risk factors for first events of coronary heart disease in patients with high blood pressure. All subjects had hypertension treated with medication. The 248 cases presented with new coronary heart disease from 1982 through 1984, and the 737 controls were a probability sample of health maintenance organization patients free of coronary heart disease. The health maintenance organization's computerized pharmacy database identified recent stoppers--patients who did not fill their prescriptions regularly enough to be at least 80% compliant. After adjustment for potential confounding factors, subjects who had recently stopped using beta-blockers had a transient fourfold increase in the relative risk of coronary heart disease (relative risk, 4.5; 95% confidence interval, 1.1 to 18.5). The association was specific to beta-blockers but not diuretics. A withdrawal syndrome immediately following the cessation of beta-blocker use may be an acute precipitant of angina and myocardial infarction in hypertensive patients who have no prior history of coronary heart disease.
我们开展了一项基于人群的病例对照研究,以探究高血压患者首次发生冠心病的危险因素。所有受试者均接受药物治疗高血压。248例患者于1982年至1984年期间首次发生冠心病,737名对照为健康维护组织中无冠心病的患者的概率样本。健康维护组织的计算机化药房数据库识别出近期停药者,即那些未按足够规律频次取药以致依从性低于80%的患者。在对潜在混杂因素进行校正后,近期停用β受体阻滞剂的受试者冠心病相对风险瞬间增加四倍(相对风险为4.5;95%置信区间为1.1至18.5)。这种关联特定于β受体阻滞剂,而非利尿剂。在无冠心病既往史的高血压患者中,停用β受体阻滞剂后立即出现的戒断综合征可能是心绞痛和心肌梗死的急性促发因素。